iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit
NASHUA, N.H., March 26, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief Executive Officer, and Stacey Stevens, Chief Strategy & Commercial Officer, will be present a corporate overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit, being held March 27 in New York City.
| Presentation Details: | |
| Date: | Wednesday, March 27 |
| Time: | 2:00pm Eastern Time |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Investor Relations:
LifeSci Advisors
Jeremy Feffer
(212) 915-2568
jeremy@lifesciadvisors.com
or:
Media Inquiries:
ARPR, on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209
paul@arpr.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
